Relaxin-3/RXFP3 system regulates alcohol-seeking

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages 20789-20794

  Ryan, Philip J ^a,b   Kastman, Hanna E ^a   Krstew, Elena V ^a   Rosengren, K Johan ^a   Hossain, Mohammed Akhter ^a,b,c   Churilov, Leonid ^a   Wade, John D ^a,b   Gundlach, Andrew L ^a   Lawrence, Andrew J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Dependence

Indexed keywords

ALCOHOL; RELAXIN 3; SUCROSE;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CELL NUCLEUS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; MALE; NONHUMAN; PRIORITY JOURNAL; PROCEDURAL MEMORY; RAT; RELAPSE; STRESS; STRIA TERMINALIS;

EID: 84890818751     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317807110     Document Type: Article

References (51)

1. Rehm J, et al. (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-Use disorders. Lancet 373(9682):2223-2233.
2. American Psychiatric Association (2000) DSM IV TR: Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Washington, DC), 4th Ed.
3. O'Brien CP, Volkow N, Li TK (2006) What's in a word Addiction versus dependence in DSM-V. Am J Psychiatry 163(5):764-765.
4. Hasin DS, Stinson FS, Ogburn E, Grant BF (2007) Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64(7):830-842.
5. Thavorncharoensap M, Teerawattananon Y, Yothasamut J, Lertpitakpong C, Chaikledkaew U (2009) The economic impact of alcohol consumption: A systematic review. Subst Abuse Treat Prev Policy 4:20.
6. Bouza C, Angeles M, Muñoz A, Amate JM(2004) Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review. Addiction 99(7):811-828.
7. Heilig M, Goldman D, Berrettini W, O'Brien CP (2011) Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12(11):670-684.
8. Jupp B, Lawrence AJ (2010) New horizons for therapeutics in drug and alcohol abuse. Pharmacol Ther 125(1):138-168.
9. Spanagel R, Kiefer F (2008) Drugs for relapse prevention of alcoholism: Ten years of progress. Trends Pharmacol Sci 29(3):109-115.
10. O'Brien CP (2005) Anticraving medications for relapse prevention: A possible new class of psychoactive medications. Am J Psychiatry 162(8):1423-1431.
11. Bathgate RAD, et al. (2002) Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 277(2): 1148-1157.
12. Liu C, et al. (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-Protein-Coupled receptor GPCR135. J Biol Chem 278(50):50754-50764.
13. Wilkinson TN, Speed TP, Tregear GW, Bathgate RAD (2005) Evolution of the relaxinlike peptide family. BMC Evol Biol 5(1):14.
14. Bathgate RAD, Ivell R, Sanborn BM, Sherwood OD, Summers RJ (2006) International Union of Pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58(1):7-31.
15. Burazin TCD, et al. (2002) Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain. J Neurochem 82(6):1553-1557.
16. Smith CM, Ryan PJ, Hosken IT, Ma S, Gundlach AL (2011) Relaxin-3 systems in the brain: The first 10 years. J Chem Neuroanat 42(4):262-275.
17. Koob GF (2010) The role of CRF and CRF-Related peptides in the dark side of addiction. Brain Res 1314:3-14.
18. Nestler EJ (2005) Is there a common molecular pathway for addiction Nat Neurosci 8(11):1445-1449.
19. Ma S, et al. (2007) Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-Protein-Coupled receptor-135 in the rat. Neuroscience 144(1):165-190.
20. Tanaka M, et al. (2005) Neurons expressing relaxin 3/INSL 7 in the nucleus incertus respond to stress. Eur J Neurosci 21(6):1659-1670.
21. Sutton SW, et al. (2004) Distribution of G-Protein-Coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing. Neuroendocrinology 80(5):298-307.
22. Ryan PJ, Ma S, Olucha-Bordonau FE, Gundlach AL (2011) Nucleus incertus: An emerging modulatory role in arousal, stress and memory. Neurosci Biobehav Rev 35(6):1326-1341.
23. McGowan BM, et al. (2005) Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology 146(8):3295-3300.
24. McGowan BM, et al. (2006) Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 136(1-3):72-77.
25. Ganella DE, Ryan PJ, Bathgate RAD, Gundlach AL (2012) Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-Selective peptides: Functional and therapeutic implications. Behav Pharmacol 23(5-6):516-525.
26. Banerjee A, Shen PJ, Ma S, Bathgate RAD, Gundlach AL (2010) Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology 58(1):145-155.
27. Watanabe Y, Miyamoto Y, Matsuda T, Tanaka M (2011) Relaxin-3/INSL7 regulates the stress-Response system in the rat hypothalamus. J Mol Neurosci 43(2):169-174.
28. Smith CM, et al. (2010) Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. J Comp Neurol 518(19):4016-4045.
29. Smith CM, Hosken IT, Sutton SW, Lawrence AJ, Gundlach AL (2012) Relaxin-3 null mutation mice display a circadian hypoactivity phenotype. Genes Brain Behav 11(1): 94-104.
30. Lawrence AJ (2010) Regulation of alcohol-Seeking by orexin (hypocretin) neurons. Brain Res 1314:124-129.
31. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437(7058):556-559.
32. Ash BL, Zanatta SD, Williams SJ, Lawrence AJ, Djouma E (2011) The galanin-3 receptor antagonist, SNAP 37889, reduces operant responding for ethanol in alcohol-Preferring rats. Regul Pept 166(1-3):59-67.
33. Duncan EA, Proulx K, Woods SC (2005) Central administration of melanin-Concentrating hormone increases alcohol and sucrose/quinine intake in rats. Alcohol Clin Exp Res 29(6):958-964.
34. Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology (Berl) 168(1-2):3-20.
35. Epstein DH, Preston KL, Stewart J, Shaham Y (2006) Toward a model of drug relapse: An assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl) 189(1):1-16.
36. Liu C, et al. (2005) Relaxin-3/insulin-Like peptide 5 chimeric peptide, a selective ligand for G protein-Coupled receptor (GPCR)135 and GPCR142 over leucine-Rich repeatcontaining G protein-Coupled receptorr Mol Pharmacol 67(1):231-240.
37. Kuei C, et al. (2007) R3(BÄ23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: In vitro and in vivo characterization. J Biol Chem 282(35):25425-25435.
38. Haugaard-Kedström LM, et al. (2011) Design, synthesis, and characterization of a single-Chain peptide antagonist for the relaxin-3 receptor RXFP3. J Am Chem Soc 133(13):4965-4974.
39. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006) The orexin system regulates alcohol-Seeking in rats. Br J Pharmacol 148(6):752-759.
40. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-Induced reinstatement of alcohol seeking and alcohol self-Administration in rats. Psychopharmacology (Berl) 179(2):366-373.
41. Silberman Y, Matthews RT, Winder DG (2013) A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis. J Neurosci 33(3):950-960.
42. Buffalari DM, See RE (2011) Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: Effects on conditioned cue-Induced reinstatement and its enhancement by yohimbine. Psychopharmacology (Berl) 213(1):19-27.
43. Erb S, Stewart J (1999) A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-Releasing factor on stress-Induced reinstatement of cocaine seeking. J Neurosci 19(20):RC35.
44. Ma S, et al. (2009) Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus. Learn Mem 16(11):730-742.
45. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37(4):577-582.
46. Valentino R, Aston-Jones G (2010) Special issue on neuropeptides in stress and addiction: Overview. Brain Res 1314:1-2.
47. Volkow ND (2004) The reality of comorbidity: Depression and drug abuse. Biol Psychiatry 56(10):714-717.
48. Hossain MA, et al. (2008) The A-Chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. J Biol Chem 283(25):17287-17297.
49. Haugaard-Jönsson LM, et al. (2008) Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist. J Biol Chem 283(35):23811-23818.
50. Paxinos G, Watson C (2007) The Rat Brain in Stereotaxic Coordinates (Academic Press, London), 6th Ed.
51. Jupp B, Krivdic B, Krstew E, Lawrence AJ (2011) The orexin receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 1391:54-59.